美股新聞 標題聯播 · 近 24 小時 305 則 · 28 個來源 · 最新 9/20 06:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · DNTH近 30 天 4 則 · 第 1 / 1 頁
- Dianthus (DNTH) Piles Up Clinical Wins While Its Losses Widen
- UiPath downgraded, Shell upgraded: Wall Street's top analyst calls
- Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Dianthus Therapeutics to Participate in Three Investor Conferences During September
- Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Tops Revenue Estimates
- Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results
- Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases
- Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
- Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
- Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
- Chronic Inflammatory Demyelinating Polyneuropathy Market Gains Traction During the Forecast Period (2026-2036) with Advancing Clinical Research Activities | DelveInsight
- DNTH Shares Surge 89% Over the Past Six Months: What's Driving It?
- Dianthus CIDP Data Lift Prospects While Funding And Dilution Risks Linger
- DNTH Stock Clocks Best Day In Over 3 Months On Strong Nerve Disorder Study Results
- Sanofi, An Argenx Rival, Bites The Dust — But A Third Biotech Took The Biggest Hit
- Stocks Settle Sharply Lower on Escalating Middle East Tensions
- Stocks Resume Decline as Chipmakers and AI Companies Fall
- Stocks Fall on Weakness in Tech and Trucking Companies
- Will Orphan Drug Status And Advancing Autoimmune Pipeline Change Dianthus Therapeutics' (DNTH) Narrative
- Dianthus Therapeutics (DNTH) Appears Attractive Amid Solid Product Pipeline
- Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish
- Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。